Venable·IP / PATENT
USPTO Director Explains Denial of Biocon PGR on Regeneron's EYLEA Patent
The Director issued a written opinion on September 24, 2026 explaining why post-grant review petition PGR2026-00039, which Biocon filed against Regeneron's U.S. Patent No. 12,168,036, was not instituted.
post-grant-reviewuspto-patent-trialsregeneronbioconeyleabiologics
Read the original firm alert → Saturday, October 3, 2026